Related Experiment Video
Updated: Apr 8, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
6.3K
Aberrant methylation patterns in cancer: a clinical view
Alja Videtic Paska1, Petra Hudler1
1Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Biochemia Medica
|June 26, 2015
Summary
Aberrant DNA methylation patterns in tumors are emerging as valuable biomarkers. These epigenetic changes in cancer can be used for early diagnosis, predicting drug response, and guiding patient assessment.
Area of Science:
- Epigenetics
- Molecular Biology
- Genomics
Background:
- Epigenetic mechanisms like DNA methylation regulate gene expression.
- Aberrant DNA methylation is linked to complex diseases, including various cancers.
- Advances in detection technologies have led to significant data on methylation changes.
Purpose of the Study:
- To explore the potential of DNA methylation changes in malignancies for developing diagnostic tools.
- To highlight the application of DNA methylation as biomarkers for cancer detection and drug sensitivity.
- To discuss the clinical translation of methylation patterns into diagnostic assays.
Main Methods:
- Review of current literature on DNA methylation in cancer.
- Analysis of aberrant methylation signatures in breast, pancreatic, colorectal, and gastric cancers.
- Examination of existing and potential clinical applications of methylation biomarkers.
Main Results:
- DNA methylation changes in tumors can serve as biomarkers for early cancer detection in accessible tissues.
- Methylation signatures are effective in determining drug sensitivity.
- Specific gene promoter methylation patterns (e.g., MGMT, SHOX2, SEPT9) are already used in clinical assays.
Conclusions:
- DNA methylation patterns in tumor cells are increasingly recognized as promising biomarkers for routine diagnostics.
- These epigenetic alterations offer potential as therapeutic targets.
- Methylation-based assays are becoming valuable adjunct tools for patient assessment in oncology.
Related Concept Videos
01:37Epigenetic Regulation
4.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.2K
01:46Epigenetic Regulation
34.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.4K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
02:53Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.6K
03:03mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K